Suppr超能文献

相似文献

3
Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis.
Clin Exp Rheumatol. 2024 Aug;42(8):1623-1628. doi: 10.55563/clinexprheumatol/ua07a2. Epub 2024 Jul 3.
4
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Arthritis Rheumatol. 2014 Mar;66(3):726-30. doi: 10.1002/art.38277.
6
Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin.
Arthritis Care Res (Hoboken). 2023 Jul;75(7):1469-1480. doi: 10.1002/acr.24998. Epub 2023 Mar 13.
8
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.
Autoimmun Rev. 2020 Feb;19(2):102452. doi: 10.1016/j.autrev.2019.102452. Epub 2019 Dec 12.

引用本文的文献

5
6
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study.
Lancet Rheumatol. 2022 Jun 23;4(7):e507-e516. doi: 10.1016/S2665-9913(22)00094-7. eCollection 2022 Jul.
10
Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases.
Int J Mol Sci. 2021 Apr 15;22(8):4095. doi: 10.3390/ijms22084095.

本文引用的文献

1
The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.
Arthritis Rheumatol. 2020 Aug;72(8):1341-1349. doi: 10.1002/art.41265. Epub 2020 Jul 20.
2
Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.
Ann Rheum Dis. 2019 Oct;78(10):1371-1378. doi: 10.1136/annrheumdis-2019-215770. Epub 2019 Aug 7.
3
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327.
4
Potential biomarkers in patients with systemic sclerosis.
Int J Rheum Dis. 2018 Jan;21(1):261-265. doi: 10.1111/1756-185X.13196. Epub 2017 Oct 11.
6
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin.
J Invest Dermatol. 2017 Jan;137(1):62-70. doi: 10.1016/j.jid.2016.08.027. Epub 2016 Sep 14.
7
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis.
Int J Cardiol. 2016 Nov 15;223:385-389. doi: 10.1016/j.ijcard.2016.08.246. Epub 2016 Aug 13.
9
Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
Rheumatology (Oxford). 2016 Jun;55(6):1112-6. doi: 10.1093/rheumatology/kew017. Epub 2016 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验